Urge your members of Congress to support continued medical research funding
The American Society of Hematology has announced the names of 23 hematologists participating in the 2017 ASH Clinical Research Training Institute in Latin America. This education and mentorship program will be held on April 5-6, 2017, in Uruguay, prior to the Society’s Highlights of ASH meeting in Latin America. This program is designed to prepare current hematology fellows and junior faculty members working in Latin America for careers in clinical research.
In a new analysis, patients with atrial fibrillation showed a substantially reduced risk of dangerous bleeding in the brain, known as intracranial hemorrhage, when taking the newer anticoagulant apixaban compared to those taking warfarin. The study also showed that taking aspirin increased the risk of intracranial hemorrhage, especially in older patients.
ASH's President responded to the White House’s proposed fiscal year 2018 budget, which proposes a nearly $6 billion cut to the National Institutes of Health.
In response to yesterday's signing of the Administration's revised executive order on immigration (Executive Order 13780), American Society of Hematology President Kenneth C. Anderson, MD, of the Dana-Farber Cancer Institute, issued the following statement.
In response to today’s introduction of the Cancer Drug Parity Act (H.R. 1409) by Representatives Leonard Lance (R-NJ) and Brian Higgins (D-NY), ASH President Kenneth C. Anderson, MD, of the Dana-Farber Cancer Institute, issued the following statement
The American Society of Hematology and the European Hematology Association have announced the names of 20 early-career hematologists who will participate in the joint 2017 Translational Research Training in Hematology program.
The College of American Pathologists and the American Society of Hematology have published an evidence-based guideline that addresses the initial work-up of acute leukemia. The guideline was published in an early online edition of the Archives of Pathology and Laboratory Medicine on February 22. In addition to the full guideline, the recommendations will also be available in a printed pocket guide and digitally in the ASH Pocket Guides app.
New research suggests that young patients with acute lymphocytic leukemia (ALL) — the most common type of pediatric cancer — and their and their parents are likely to report to their physician that they took more of their anti-cancer medication than they actually did.
As the world's leading organizations representing laboratory researchers, physician-scientists, clinicians, the nation’s cancer centers, and patient advocates committed to improved care for patients with cancer and blood diseases, we express our deep concern about the Administration’s executive order that has denied U.S. entry to people who bring unique expertise to the practice of medicine and the conduct of cancer and biomedical research.
ASH President Kenneth C. Anderson, MD, has submitted the Society’s 2017 policy priorities to Secretary Designee of the United States Department of Health and Human Services Tom Price, MD. The letter affirms the Society’s commitment to working with policymakers on the following issues important to hematology.
Urge your members of Congress to support continued medical research funding.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology